Bacopa monnieri extract (bacosides)
Bacopa Monnieri Extract (Synapsa / Bacopin) · also known as Bacopa monnieri, Water hyssop, Bacopa, Bacosides
Bacopa is a traditional herb used to boost cognition. A meta-analysis showed that taking it daily for about 12 weeks can modestly improve attention and information processing speed. Its effects on BDNF and on the cholinergic and monoamine systems come mostly from animal studies, and results in humans are mixed.
Clinical uses and human evidence
Anxiety and stress
Studies (2)
- Lopresti 2025 · Clin Drug Investig · RCT · n=101 — The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
- Calabrese 2008 · J Altern Complement Med · RCT · n=54 — Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial
Memory
Studies (2)
- Tiemtad 2026 · Phytomedicine · Meta-analysis · n=2107 — Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
- Lopresti 2025 · Clin Drug Investig · RCT · n=101 — The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Attention and focus
Studies (2)
- Tiemtad 2026 · Phytomedicine · Meta-analysis · n=2107 — Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
- Lopresti 2025 · Clin Drug Investig · RCT · n=101 — The Effects of a Bacopa monnieri Extract (Bacumen(®)) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Age-related cognitive decline
Mechanisms of action
Neurotrophic factor synthesis and TrkB/A receptor activation
One randomized trial in 80 people found higher serum BDNF than in the placebo group after 300 mg/day for 12 weeks. An open-label study in older adults, however, found no change in serum BDNF after 12 weeks. Changes in hippocampal TrkB receptors and dendritic spines have been seen mainly in animals.
Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)
A randomized trial in 60 people observed lower plasma acetylcholinesterase activity at some time points. However, peripheral enzyme activity does not show how much the enzyme is inhibited in the brain. Changes in choline acetyltransferase in the cerebral cortex were not measured directly, and the extract used was standardized differently from this product.
Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)
In young rats, expression of tryptophan hydroxylase-2 and the serotonin transporter in the hippocampus changed. That does not prove that serotonin release increases in the adult brain. A human randomized trial found no significant change in monoamine oxidase activity, and there is no human evidence yet for an anti-anxiety effect.
Safety and drug interactions
Additive sedation
Some people become drowsy after taking it. Each of these has some sedative or sleep-promoting effect. Taken together, they may cause daytime drowsiness and slower reactions. Do not drive or work at heights after taking them.